Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uterine Serous Carcinoma”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Testing effectiveness (Phase 2)Study completedNCT00025467
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT01935934
What this trial is testing

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 102
Not applicableStudy completedNCT04823871
What this trial is testing

Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing

Who this might be right for
Ovarian Epithelial CancerCarcinoma in SituOvarian Cancer
Paul Speiser, Prof.MD, 406
Very early researchActive Not RecruitingNCT04494113
What this trial is testing

Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy

Who this might be right for
Endometrial Serous Adenocarcinoma
National Cancer Institute (NCI) 12
Not applicableUnknownNCT03150121
What this trial is testing

Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage

Who this might be right for
Ovarian CancerOvarian CarcinomaFallopian Tube Cancer+2 more
Sheba Medical Center 500
Not applicableStudy completedNCT01836484
What this trial is testing

Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma

Who this might be right for
Surgically Staged Endometrial and Cervical CarcinomaCervical Cancer: Invasive Disease, FIGO Stage 1B1 or HigherEndometrial Cancer+3 more
Barts & The London NHS Trust 162
Early research (Phase 1)Looking for participantsNCT05950464
What this trial is testing

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Who this might be right for
Recurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid Adenocarcinoma+6 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Active Not RecruitingNCT05858736
What this trial is testing

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more
OncoC4, Inc. 18
Testing effectiveness (Phase 2)WithdrawnNCT03836157
What this trial is testing

Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial AdenocarcinomaEndometrial Serous Adenocarcinoma+1 more
University of Oklahoma
Large-scale testing (Phase 3)Study completedNCT00005583
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer

Who this might be right for
Endometrial Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 400
Testing effectiveness (Phase 2)Study completedNCT01210222
What this trial is testing

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+4 more
Gynecologic Oncology Group 35
Testing effectiveness (Phase 2)Ended earlyNCT00506779
What this trial is testing

Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma

Who this might be right for
Uterine Cancer
M.D. Anderson Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT00002493
What this trial is testing

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerPsychosocial Effects of Cancer and Its Treatment
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00147680
What this trial is testing

Uterine Papillary Serous Cancer (UPSC) Trial

Who this might be right for
Uterine Cancer
Queensland Centre for Gynaecological Cancer 30
Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00888173
What this trial is testing

Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+6 more
Gynecologic Oncology Group 45
Not applicableStudy completedNCT02039388
What this trial is testing

Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma

Who this might be right for
Ovarian Epithelial CancerCarcinoma in SituOvarian Cancer
Medical University of Vienna 701
Testing effectiveness (Phase 2)Study completedNCT00515073
What this trial is testing

Papillary Serous Carcinoma of the Endometrium

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01307631
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+2 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT01005329
What this trial is testing

Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+9 more
National Cancer Institute (NCI) 34
Load More Results